Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-14

Clinical Trial Update: An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

View source ↗

Summary

An observational, multicenter study evaluating how Doptelet (eltrombopag) is used and its effectiveness in patients with immune thrombocytopenia. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOPTELET (avatrombopag)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Immune Thrombocytopenia, ITP | Status: COMPLETED